Format

Send to

Choose Destination
See comment in PubMed Commons below
J Investig Dermatol Symp Proc. 2013 Dec;16(1):S58. doi: 10.1038/jidsymp.2013.23.

Clinical response to combined therapy of cyclosporine and prednisone.

Author information

1
Pediatric Endocrinology, Montefiore Medical Center Children's Hospital at Montefiore, Bronx, New York, USA.

Abstract

Reported is a patient with severe alopecia areata, multiple autoimmune diseases (chronic lymphocytic thyroidis, primary ovarian failure), and Down syndrome. She had a poor response to topical treatment with glucocorticoids and minoxidil, but showed some improvement with glucocorticoid injections. At the time of evaluation, she had hair loss on 85-90% of her scalp. She was treated initially with oral prednisone 50 mg per day for 2 weeks, followed by a 3-month course of prednisone 10 mg per day and cyclosporine 125 mg (4 mg kg(-1)) two times per day. She responded well with excellent regrowth of hair on the scalp, and prednisone was tapered and ultimately discontinued. Importantly, her parents noted marked improvement in sense of well-being. Several months after discontinuing treatment, she developed hyperpigmentation on the trunk consistent with confluent and reticulated papillomatosis; she has several known risk factors for this disorder, but it is not clear if this is related to her previous treatment.

PMID:
24326561
DOI:
10.1038/jidsymp.2013.23
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center